- 1. HIV
- [human immunodeficiency virus vaccine ( HL7V3.0 )] (UMLS (HL7) C0086413) =Pharmacologic Substance; Immunologic Factor ;
=Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType | - 17. HIV receptor
- [Cellular receptors that bind the human immunodeficiency virus that causes AIDS. Included are CD4 ANTIGENS, found on T4 lymphocytes, and monocytes/macrophages, which bind to the HIV ENVELOPE PROTEIN GP120. ( MSH )] (UMLS (CSP) C0034816) =Amino Acid, Peptide, or Protein; Immunologic Factor; Receptor
|
- 2. HIV
- [species of Lentivirus, subgenus primate lentiviruses, formerly designated T cell lymphotropic virus type III/lymphadenopathy associated virus (HTLV-III/LAV); it is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the Acquired Immunodeficiency Syndrome (AIDS). ( CSP )] (UMLS (NCI) C0019682) =Virus ;
=Lentivirus;
=AIDS virus;
HIV 2;
| - 18. HIV related
- [HIV and AIDS related item ( HL7V3.0 )] (UMLS (HL7) C1550476) =Idea or Concept =ConfidentialityByInfoType;
|
- 3. HIV 2
- [HIV species related to HIV1 but carrying different antigenic components and with differing nucleic acid composition; shares serologic reactivity and sequence homology with the simian Lentivirus SIV and infects only T4 lymphocytes expressing the CD4 phenotypic marker. ( CSP )] (UMLS (CSP) C0019707) =Virus ;
=HIV;
| - 19. HIV risk behavior
- [ ] (UMLS (CSP) C1537021) =Individual Behavior
|
- 4. HIV Antibody
- [A substance produced by certain white blood cells in reaction to contact with HIV, the human immunodeficiency virus. ( NCI )] (UMLS (NCI) C0019683) =Amino Acid, Peptide, or Protein; Immunologic Factor
| - 20. HIV Test - Consent Refusal
- (UMLS (HL7) C1548858) =Health Care Activity =Consent Type;
|
- 5. HIV antibody positive
- [ ] (UMLS (CSP) C0920548) =Finding
| - 21. HIV Test - Disclosure
- (UMLS (HL7) C1548859) =Health Care Activity =Consent Type;
|
- 6. HIV antigen positive
- [ ] (UMLS (CSP) C0920549) =Finding
| - 22. HIV Test - Prenatal
- (UMLS (HL7) C1548860) =Health Care Activity =Consent Type;
|
- 7. HIV COUNSELING
- [ ] (UMLS (ICD9CM) C0476681) =Finding
| - 23. HIV therapy
- [ ] (UMLS (CSP) C0920551) =Therapeutic or Preventive Procedure
|
- 8. HIV diagnosis
- [ ] (UMLS (CSP) C0920550) =Diagnostic Procedure
| - 24. HIV(+) patient
- (UMLS (HL7) C1549592) =Intellectual Product =Confidentiality code;
|
- 9. HIV encephalitis
- [ ] (UMLS (CSP) C0276548) =Disease or Syndrome
| - 25. HIV-1 Tat Interacting Protein, 60kDa Gene
- [This gene plays a role in apoptosis, DNA repair and the regulation of chromatin remodeling. ( NCI )] (UMLS (NCI) C1333931) HTATIP;
HTATIP Gene =Gene or Genome ;
|
- 10. HIV envelope protein
- [general heading term for glycoproteins encoded by HIV envelope gene (env). ( CSP )] (UMLS (CSP) C0596709) =Amino Acid, Peptide, or Protein; Immunologic Factor =virus antigen;
Viral Protein =gp120;
HIV envelope protein gp41;
gp160;
| - 26. HIV-1 TAT Interactive Protein 2, 30-kD
- [Encoded by human HTATIP2 Gene (SDR Family), the ubiquitous 242-amino acid 30-kD TAT-Interacting Protein TIP30 is a nuclear and membrane-associated tumor suppressor that contains several conserved features: a semialdehyde dehydrogenase domain, a N-terminal beta-alpha-beta fold that may bind NADP(H), and a 20-amino acid N-terminal alpha helix that may enable protein docking. Proapoptotic TIP30 activity resides in the N-terminal domain. A 133-amino acid membrane-associated variant TC3 Protein contains a unique short C-terminus that confers antiapoptotic properties. TIP30 appears to be a RNA polymerase II transcription co-activator and may function as a co-activator for HIV-1 TAT protein. TIP30 may suppress metastasis. (from LocusLink, Swiss-Prot, OMIM, and NCI) ( NCI )] (UMLS (NCI) C1336577) HIV-1 TAT-Interacting Protein 30-kD;
HTATIP2;
HTATIP2 Protein;
TAT-Interacting Protein (30kD);
TAT-Interacting Protein TIP30;
=Amino Acid, Peptide, or Protein; Enzyme |
- 11. HIV envelope protein gp41
- [transmembrane glycoprotein encoded by HIV envelope gene (env) with a molecular weight of 41,000 daltons; anchors gp120 to the viral particle. ( CSP )] (UMLS (CSP) C0019692) =Amino Acid, Peptide, or Protein; Biologically Active Substance =HIV envelope protein;
| - 27. HIV-1 Tat Interactive Protein 2, 30kDa Gene
- [This gene is involved in the regulation of apoptosis and induces cell death. ( NCI )] (UMLS (NCI) C1333930) HTATIP2;
HTATIP2 Gene =Gene or Genome ;
|
- 12. HIV Infection
- [any state of infection accompanied by evidence of HIV in the body (positive test for HIV genome, cDNA, proteins, antigens, or antibodies); may be medically asymptomatic or symptomatic; use AIDS when appropriate. ( CSP )] (UMLS (NCI) C0019693) =Disease or Syndrome ;
=hypoimmunity;
Retroviridae disease;
Disease (VD), venereal;
Sexually Transmitted Diseases, Viral;
Lentivirus disease;
=Acquired Immune Deficiency;
AIDS/HIV neuropathy;
Acquired Immune Deficiency;
AIDS Dementia;
AIDS related complex;
antibody positive AIDS test;
AIDS-Associated Nephropathy;
AIDS Associated Opportunistic Infection;
HIV Enteropathy;
AIDS wasting syndrome;
AIDS Arteritis, Central Nervous System | - 28. HIV-2 INFECTION OTH DIS
- [ ] (UMLS (ICD9CM) C0375021) =Disease or Syndrome
|
- 13. HIV Leukoencephalopathy
- (UMLS (NCI) C0338422) =Disease or Syndrome
| - 29. HIV-infection (AIDS/ARC)
- (UMLS (ICPC) C0497169) (HIV-infection (AIDS/ARC); BIRUO MAKALEKI ZOLDURA(INKL.SID ET SIND. AHAIDEKIDETUAK); HIV-infektion (AIDS/ARS); HIV infectie (AIDS/ARC); HIV-INFEKTIO (AIDS/ARC); Infection HIV (SIDA et associee); HIV-Infekt/AIDS/AIDS Related Compl; (108); HIV-fertozottseg (AIDS/ARC); Infezione da HIV(AIDS/ARC); HIV-INFEKSJON/AIDS/ARS; Infeccao HIV (SIDA/SRA) ; Infeccion por V.I.H.(SIDA/CRS); HIV-INFEKTION (AIDS/ARC)) =Disease or Syndrome =BLOOD, BLOOD FORMING ORGANS, LYMPHATICS, SPLEEN; Diagnosis/Diseases Component
|
- 14. HIV neuropathy
- [ ] (UMLS (CSP) C0343757) =Disease or Syndrome
| - 30. HIV1 protease
- [ ] (UMLS (CSP) C0917721) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 15. HIV p24 Antigen
- [HIV-p24 antigen, an important core protein of the human immunodeficiency virus, is encoded by the gag gene. This protein can be detected in serum either in its free form or bound by anti-p24 antibody. Individuals who are HIV-seropositive elicit a significant immune response to p24. Thus, detection of p24 antibodies by ELISA or Western analysis is a screening method utilized to determine the presence of HIV. ( NCI )] (UMLS (NCI) C0085219) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
| - 31. Hive, Welt
- [A smooth, slightly elevated area on the body surface, which is redder or paler than the surrounding skin. It is the typical lesion of urticaria, the dermal evidence of allergy, and in sensitive persons may be provoked by mechanical irritation of the skin. ( NCI )] (UMLS (NCI) C0221232) =Sign or Symptom ;
|
- 16. HIV protease inhibitor
- [Inhibitors of HIV PROTEASE, an enzyme required for production of proteins needed for viral assembly. ( MSH )] (UMLS (CSP) C0162714) =Pharmacologic Substance =protease inhibitor;
| - 32. Hivid
- (UMLS (NCI) C0678123) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
home
